These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 28276256
1. Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: a US retrospective cohort study. Punekar RS, Fox KM, Paoli CJ, Richhariya A, Cziraky MJ, Gandra SR, Toth PP. Curr Med Res Opin; 2017 May; 33(5):869-876. PubMed ID: 28276256 [Abstract] [Full Text] [Related]
2. Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting. Simpson RJ, Tunceli K, Ramey DR, Neff DR, Kern DM, Hsieh HM, Wertz DA, Stephenson JJ, Marrett E, Tomassini JE, Jacobson TA. J Clin Lipidol; 2013 May; 7(5):399-407. PubMed ID: 24079280 [Abstract] [Full Text] [Related]
3. A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary Event. Quek RGW, Fox KM, Wang L, Li L, Gandra SR, Wong ND. Am J Cardiol; 2016 Feb 15; 117(4):495-500. PubMed ID: 26742468 [Abstract] [Full Text] [Related]
4. Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication. Wallach-Kildemoes H, Hansen EH. Eur J Clin Pharmacol; 2015 Oct 15; 71(10):1245-54. PubMed ID: 26227068 [Abstract] [Full Text] [Related]
10. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom. Cao X, Ejzykowicz F, Ramey DR, Sajjan S, Ambegaonkar BM, Mavros P, Tunceli K. Clin Ther; 2015 Apr 01; 37(4):804-15. PubMed ID: 25626487 [Abstract] [Full Text] [Related]
12. Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. Khunti K, Danese MD, Kutikova L, Catterick D, Sorio-Vilela F, Gleeson M, Kondapally Seshasai SR, Brownrigg J, Ray KK. JAMA Netw Open; 2018 Dec 07; 1(8):e185554. PubMed ID: 30646277 [Abstract] [Full Text] [Related]